Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Athanase Innovation

18.00 SEK

Less than 1K followers

ATIN

First North Stockholm

Financial Services

Financials

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+20.00 %
-10.00 %
-9.09 %
-11.76 %
-10.89 %
-12.62 %
-38.78 %
-77.53 %
-73.86 %

Athanase Innovation is an investment company active in asset management. The company specializes in investment, ownership and further management of both private and public companies. The largest business focus is found in robotics, AI, digitalization and automation. Athanase Innovation was founded in 2016 and is headquartered in Stockholm, Sweden.

Read more
Market cap
347.36M SEK
Turnover
-
Revenue
115.27M
EBIT %
-20.56 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20/2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release11/4/2025, 7:30 AM

Delårsrapport kvartal 3, 1 juli - 30 september 2025

Athanase Innovation
Regulatory press release7/11/2025, 6:30 AM

Delårsrapport kvartal 2, 1 april - 30 juni 2025

Athanase Innovation
Regulatory press release5/7/2025, 11:40 AM

Kommuniké från Athanase Innovation AB:s årsstämma den 7 maj 2025

Athanase Innovation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/6/2025, 6:30 AM

Delårsrapport kvartal 1, 1 januari - 31 mars 2025

Athanase Innovation
Regulatory press release4/3/2025, 12:00 PM

Athanase Innovation AB publicerar årsredovisningen för 2024

Athanase Innovation
Regulatory press release4/3/2025, 6:30 AM

Athanase Innovation AB kallar till årsstämma

Athanase Innovation
Regulatory press release4/2/2025, 1:30 PM

Athanase Innovation förbereder utdelning av Ivisys

Athanase Innovation
Regulatory press release2/21/2025, 7:30 AM

Bokslutskommuniké 2024

Athanase Innovation
Regulatory press release2/21/2025, 7:30 AM

Styrelsen i Athanase Innovation utreder förutsättningar för Lex-Asea utdelning

Athanase Innovation
Regulatory press release1/9/2025, 1:35 PM

Athanase Innovation AB har beslutat att utnyttja bemyndigandet om syntetiska återköp av aktier

Athanase Innovation
Regulatory press release11/25/2024, 4:40 PM

Peter Laveson slutar som VD

Athanase Innovation
Regulatory press release11/21/2024, 12:30 PM

Athanase Innovation AB offentliggör slutligt utfall i det frivilliga inlösenprogrammet

Athanase Innovation
Regulatory press release11/20/2024, 3:05 PM

Athanase Innovation AB offentliggör preliminärt utfall i det frivilliga inlösenprogrammet

Athanase Innovation
Regulatory press release11/5/2024, 9:30 AM

Kommuniké från extra bolagsstämma i Athanase Innovation AB den 5 november 2024

Athanase Innovation
Regulatory press release11/5/2024, 7:30 AM

Delårsrapport kvartal 3, 1 juli - 30 september 2024

Athanase Innovation
Regulatory press release10/16/2024, 2:40 PM

Athanase Innovation AB kallar till extra bolagsstämma och föreslår att stämman beslutar om minskning av aktiekapitalet med indragning av aktier

Athanase Innovation
Regulatory press release10/16/2024, 2:05 PM

Styrelsen i Athanase Innovation AB föreslår frivilligt inlösenprogram till bolagets aktieägare och meddelar sin avsikt att lägga fram förslag till beslut om avnotering

Athanase Innovation
Regulatory press release9/27/2024, 2:00 PM

Athanase Innovation initierar en strategisk översyn, avbryter Industrial Tech-fonden, samt undersöker förutsättningarna för ett frivilligt inlösenprogram

Athanase Innovation
Regulatory press release9/23/2024, 8:00 AM

Syntetiska återköp av egna aktier i Athanase Innovation

Athanase Innovation
Regulatory press release9/16/2024, 8:00 AM

Syntetiska återköp av egna aktier i Athanase Innovation

Athanase Innovation
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.